
What happened
American Express Global Business Travel (GBTG) reported Q4 revenues of $792 million(約1300億円), a 34% year-over-year increase that exceeded analyst expectations by 0.5%. However, full-year EBITDA guidance slightly missed expectations, causing the stock to decline 3.8% after the earnings release; it recovered with a 0.73% gain today.
Why it matters
Wall Street analysts have assigned GBTG a 'Strong Buy' consensus, with 6 out of 7 analysts recommending purchase and a median price target of $9.00, implying 64.2% upside from its current trading price of $5.52. The company is positioned as a critical partner for businesses navigating global travel and expense management, benefiting from post-pandemic recovery and the shift toward cloud-based software solutions.
What to watch
GBTG trades at a Price-to-Earnings ratio of 26.30 and a Price-to-Sales ratio of 1.06, with a market capitalization of $2.89 billion(約4600億円). The stock has declined 29.4% over the past six months and trades 36.6% below its 52-week high of $8.64, reflecting sensitivity to economic conditions. A strategic partnership announced in January 2026 between parent investor Certares and Italian rail firm FS aims to promote high-speed rail for business travelers, potentially diversifying revenue streams.
Summaries like this, in your inbox every morning.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Western Digital's fiscal 2026 revenue rose 35.7% to $12.92B, as management says roughly 80% of hyperscale data…

Albert Bourla told The Wall Street Journal's CEO Brief that Pfizer moved AI decisions from a central expert te…

T-Mobile is using AI to reshape its network investment and resilience, according to RCR Wireless News

Alpha Modus, an AI company based in Cornelius, obtained key rulings in its patent disputes with Lowe's and oth…

Google Research published a guide on RRSI, a method for AI agents that improve themselves by reviewing their o…

GSK is adopting Chai Discovery's AI models for drug discovery after the models passed wet-lab validation
